Actinic keratoses. Pathogenesis, clinical aspect and modern therapeutic options;Aktinische keratosen. Pathogenese, klinik und moderne therapieoptionen

Hautarzt

Volumn 65, Issue 3, 2014, Pages 241-254

  Strunk, T ^a   Szeimies, R M ^a  

^a Knappschaftskrankenhaus Recklinghausen   (Germany)

Author keywords

Atypical keratinocytes; Field cancerization; Photodynamic therapy; Squamous cell carcinoma; UV exposition

Indexed keywords

COSMETIC; ANTINEOPLASTIC AGENT; DERMATOLOGICAL AGENT; PHOTOSENSITIZING AGENT;

ACTINIC KERATOSIS; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; GENE MUTATION; HUMAN; KERATINOCYTE; ONCOGENE H RAS; PATHOGENESIS; PREVALENCE; RISK FACTOR; SQUAMOUS CELL CARCINOMA; TUMOR INVASION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION; EPIDEMIOLOGY; GERMANY; KERATOSIS, ACTINIC; PHOTOCHEMOTHERAPY; PROCEDURES;

ANTINEOPLASTIC AGENTS; DERMATOLOGIC AGENTS; GERMANY; HUMANS; KERATOSIS, ACTINIC; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RISK FACTORS;

EID: 84898467835     PISSN: 00178470     EISSN: 14321173     Source Type: Journal    
DOI: 10.1007/s00105-014-2759-6     Document Type: Article

References (56)

1. Pinkus H (1958) Keratosis senilis: a biologic concept of its pathogenesis and diagnosis based on the study of normal epidermis and 1730 seborrheic and senile keratoses. Am J Clin Pathol 29:193-207
2. Memon AA, Tomenson JA, Bothwell J et al (2000) Prevalence of solar damage and actinic keratosis in a Merseyside population. Br J Dermatol 142:1154-1159 (Pubitemid 30418302)
3. Schaefer I, Augustin M, Spehr C et al (2013) Prevalence and risk factors of actinic keratoses in Germany - analysis of multisource data. J Eur Acad Dermatol Venereol 28:309-313
4. Traianou A, Ulrich M, Apalla Z et al (2012) Risk factors for actinic keratosis in eight European centres: a case-control study. Br J Dermatol 167(Suppl 2):36-42
5. Hensen P, Müller ML, Haschemi R et al (2009) Predisposing factors of actinic keratosis in a North-West German population. Eur J Dermatol 19:345-354
6. Oldenburg M, Kuechmeister B, Ohnemus U et al (2013) Actinic keratosis among seafarers. Arch Dermatol Res 305:787-796
7. Schmitt J, Seidler A, Diepgen TL et al (2011) Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis. Br J Dermatol 164:291-307
8. Ulrich C, Schmook T, Nindl I et al (2003) Cutaneous precancers in organ transplant recipients: an old enemy in a new surrounding. Br J Dermatol 149(Suppl 2):40-42 (Pubitemid 38064516)
9. Babilas P, Landthaler M, Szeimies RM (2003) Actinic keratoses. Hautarzt 54:551-562
10. Luo JL, Tong WM, Yoon JH et al (2001) UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin. Cancer Res 61(22):8158-8163
11. Tomas D (2009) Apoptosis, UV-radiation, precancerosis and skin tumors. Acta Med Croatica 63(Suppl 2):53-58
12. Pierceall WE, Goldberg LH, Tainsky MA et al (1991) Ras gene mutation and amplification in human nonmelanoma skin cancers. Mol Carcinog 4:196-202
13. Ratushny V, Gober MD, Hick R et al (2012) From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest 122:464-472
14. Zaravinos A, Kanellou P, Spandidos DA (2009) Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers. Br J Dermatol 162:325-331
15. Weissenborn SJ, Nindl I, Purdie K et al (2005) Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 125:93-97 (Pubitemid 40981429)
16. Pfister H (2008) HPV and skin neoplasia. Hautarzt 59:26-30
17. Nashan D, Meiss F, Müller M (2013) Therapeutic strategies for actinic keratoses-a systematic review. Eur J Dermatol 23:14-32
18. Röwert-Huber J, Patel MJ, Forschner T et al (2007) Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol 156(Suppl 3):8-12 (Pubitemid 46632512)
19. Cockerell CJ (2003) Pathology and pathobiology of the actinic (solar) keratosis. Br J Dermatol 149(Suppl 66):34-36
20. Ramos-Ceballos FI, Ounpraseuth ST, Horn TD (2008) Diagnostic concordance among dermatopathologists using a three-tiered keratinocytic intraepithelial neoplasia grading scheme. J Cutan Pathol 35:386-391 (Pubitemid 351363770)
21. Werner RN, Sammain A, Erdmann R et al (2013) The natural history of actinic keratosis: a systematic review. Br J Dermatol 169:502-518
22. Marks R, Foley P, Goodman G et al (1986) Spontaneous remission of solar keratoses: the case for conservative management. Br J Dermatol 115:649-655 (Pubitemid 17181888)
23. Dodson JM, DeSpain J, Hewett JE et al (1991) Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. Arch Dermatol 127:1029-1031
24. Fuchs A, Marmur E (2007) The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma. Dermatol Surg 33:1099-1101 (Pubitemid 47339694)
25. Ulrich C, Jürgensen JS, Degen A et al (2009) Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol 161(Suppl 3):78-84
26. Andrews MD (2004) Cryosurgery for common skin conditions. Am Fam Physician 69:2365-2372
27. Thai KE, Fergin P, Freeman M (2004) A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol 43:687-692 (Pubitemid 39276301)
28. Kaufmann R, Spelman L, Weightman W et al (2008) Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities. Br J Dermatol 158:994-999 (Pubitemid 351521450)
29. Morton CA, Szeimies RM, Sidoroff A, Braathen LR (2013) European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol 27: 536-544
30. Wollina U, Konrad H, Karamfilov T (2001) Treatment of common warts and actinic keratoses by Er:YAG laser. J Cutan Laser Ther 3:63-66 (Pubitemid 34112670)
31. Stockfleth E, Kerl H, Zwingers T et al (2011) Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results. Br J Dermatol 165:1101-1108
32. Hauschild A, Stockfleth E, Popp G et al (2009) Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies. Br J Dermatol 160:1066-1074
33. Szeimies RM, Stockfleth E, Popp G et al (2010) Long-term follow-up of photodynamic therapy with a selfadhesive 5-aminolaevulinic acid patch: 12 months data. Br J Dermatol 162:410-414
34. Pflugfelder A, Welter AK, Leiter U et al (2012) Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group. J Eur Acad Dermatol Venereol 26:48-53
35. Iraji F, Siadat AH, Asilian A et al (2008) The safety of diclofenac for the management and treatment of actinic keratoses. Expert Opin Drug Saf 7:167-172 (Pubitemid 351447699)
36. Alomar A, Bichel J, McRae S (2007) Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head. Br J Dermatol 157:133-141 (Pubitemid 46934262)
37. Lebwohl M, Dinehart S, Whiting D et al (2004) Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehiclecontrolled trials. J Am Acad Dermatol 50:714-721 (Pubitemid 38580548)
38. Korman N, Moy R, Ling M et al (2005) Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Arch Dermatol 141:467-473 (Pubitemid 40547405)
39. Swanson N, Abramovits W, Berman B et al (2010) Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebocontrolled studies of daily application to the face and balding scalp for two 2-week cycles. J Am Acad Dermatol 62:582-590
40. Hanke CW, Beer KR, Stockfleth E et al (2010) Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles. J Am Acad Dermatol 62:573-581
41. Lebwohl M, Swanson N, Anderson LL et al (2012) Ingenol mebutate gel for actinic keratosis. N Engl J Med 366:1010-1019
42. Lebwohl M, Shumack S, Stein Gold L et al (2013) Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses. JAMA Dermatol 149:666-670
43. Jury CS, Ramraka-Jones VS, Gudi V et al (2005) A randomized trial of topical 5% 5-fluorouracil (Efudix cream) in the treatment of actinic keratoses comparing daily with weekly treatment. Br J Dermatol 153:808-810 (Pubitemid 41415910)
44. Loven K, Stein L, Furst K et al (2002) Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis. Clin Ther 24:990-1000 (Pubitemid 34734743)
45. Sander CA, Pfeiffer C, Kligman AM et al (1997) Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin. J Am Acad Dermatol 36(2 Pt 1):236-238 (Pubitemid 27078918)
46. Szeimies RM, Karrer S, Bäcker H (2005) Therapeutic options for epithelial skin tumors. Actinic keratoses, Bowen disease, squamous cell carcinoma, and basal cell carcinoma. Hautarzt 56:430-440 (Pubitemid 40775562)
47. Szeimies RM, Karrer S, Radakovic-Fijan S et al (2002) Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 47:258-262
48. Dirschka T, Radny P, Dominicus R et al (2013) Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol 168:825-836
49. Szeimies RM, Torezan L, Niwa A et al (2012) Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy. Br J Dermatol 167:150-159
50. Apalla Z, Sotiriou E, Chovarda E et al (2010) Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study. Br J Dermatol 162:171-175
51. Wiegell SR, Fabricius S, Stender IM et al (2011) A randomized, multicentre study of directed daylight exposure times of 1 1/2 vs. 2 1/2 h in daylightmediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp. Br J Dermatol 164:1083-1090
52. 2 laser: a randomized clinical trial. Br J Dermatol 166:1262-1269
53. Torezan L, Chaves Y, Niwa A et al (2013) A pilot split-face study comparing conventional methyl aminolevulinate-photodynamic therapy (PDT) with microneedling-assisted PDT on actinically damaged skin. Dermatol Surg 39:1197-1201
54. Serra-Guillén C, Nagore E, Hueso L et al (2012) A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes. J Am Acad Dermatol. 66:131-137
55. Ondo AL, Padilla RS, Miedler JD, Cockerell CJ et al (2012) Treatment-refractory actinic keratoses successfully treated using simultaneous combination topical 5-fluorouracil cream and imiquimod cream: a case-control study. Dermatol Surg 38:1469-1476
56. Reifenberger J, Schön MP (2003) Cutaneous epithelial tumors. Molecular biology and pathogenesis-based therapy. Hautarzt 54:1164-1170 (Pubitemid 37522361)